Howe & Rusling’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-30
Closed -$1K 803
2019
Q4
$1K Hold
30
﹤0.01% 743
2019
Q3
$1K Hold
30
﹤0.01% 752
2019
Q2
$1K Hold
30
﹤0.01% 731
2019
Q1
$1K Hold
30
﹤0.01% 729
2018
Q4
$1K Buy
+30
New +$535 ﹤0.01% 733

Other funds holding EXEL

Howe & Rusling's EXEL Position: Q1 2020 in Review

Howe & Rusling sold out of Exelixis (EXEL) in Q1 2020, closing a stake of 30 shares — an estimated $1K sold.

Howe & Rusling first reported a position in EXEL in Q4 2018 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 336 funds tracked by Wall St. Rank hold EXEL as of Q1 2020.

  • Howe & Rusling reported no remaining Exelixis position as of Q1 2020 after selling out during the quarter.
  • Howe & Rusling sold 30 Exelixis shares in Q1 2020, an estimated $1K.
  • Howe & Rusling first reported a position in Exelixis in Q4 2018 and held it in 5 quarters.
  • Howe & Rusling's Exelixis position peaked at $1K in Q4 2019.
  • 336 funds tracked by Wall St. Rank held Exelixis as of Q1 2020.

Based on Howe & Rusling's 13F filing for Q1 2020, filed 14 May 2020.